Catalyst Wire Dossier Catalyst Wire Dossier

Hemopure

HBOC-201
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Hemopure, covering 2008-05-16 to 2025-04-13. Get the full timeline:

Most recent: Clinical Trial Update: Expanded Access Study of HBOC-201 (Hemopure) for the Treatment of Life-Threatening Anemia [NA]

See pricing